1. Regional UK TTP Registry: correlation with laboratory ADAMTS 13 analysis and clinical features.
- Author
-
Scully, Marie, Yarranton, Helen, Liesner, Ri, Cavenagh, Jamie, Hunt, Beverley, Benjamin, Sylvia, Bevan, David, Mackie, Ian, and Machin, Samuel
- Subjects
- *
THROMBOTIC thrombocytopenic purpura , *METALLOPROTEINASES , *PUBLIC health records , *PUBLIC health - Abstract
Thrombotic thrombocytopenic purpura (TTP) is an acute, rare, life-threatening disorder. This report presents the South East (SE) England registry for TTP, from April 2002 to December 2006, which included 176 patients and 236 acute episodes; 75% of patients were female and 25% were male, overall median age at presentation was 42 years. Mortality was 8·5%, most cases died before treatment was instigated. The main ethnic groups were Caucasian (64%) and Afro Caribbean (27%). Seventy-seven percent of cases were idiopathic, 5% were congenital and the remaining cases had a defined precipitant. Neurological features were the most prevalent, but cardiac involvement accounted for 42% of presenting features. The overall median number of plasma exchanges (PEXs) to remission was 15; between April 2002 and December 2003, the median number of PEXs was 19 and it was 12 between January 2004 and December 2006 ( P < 0·0001). In the latter period, adjuvant therapies were reduced, but Rituximab was increased. ADAMTS 13 (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13) activity was <10% in 74% and 95% of these cases had positive IgG antibodies to ADAMTS 13. Renal impairment and delayed normalisation of platelet count were the main differences between idiopathic and secondary TTP. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF